Tenet Healthcare selloff overdone, compelling longer term, says Cantor

Tenet Healthcare’s (THC) long-term growth story remains intact after Q1, with a clean EBITDA beat and no meaningful change to the underlying narrative despite an in-line print, as near-term noise from flu, weather, and mix shifts likely obscured continued operational execution, and the selloff is overdone, the analyst tells investors in a research note.